Cargando…
HLA-matched sibling transplantation with G-CSF mobilized PBSCs and BM decreases GVHD in adult patients with severe aplastic anemia
BACKGROUND: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for severe aplastic anemia (SAA). However, graft failure and graft-versus-host disease (GVHD) are major causes of the early morbidity in Allo-HSCT. METHODS: To reduce graft failure and GVHD, we treat...
Autores principales: | Zi-Min, Sun, Hui-Lan, Liu, Liang-Quan, Geng, Xin-Bing, Wang, Wen, Yao, Xin, Liu, Kai-Yang, Ding, Yong-Sheng, Han, Hui-Zhi, Yang, Bo-lin, Tang, Juan, Tong, Wei-Bo, Zhu, Zu-Yi, Wang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023734/ https://www.ncbi.nlm.nih.gov/pubmed/21194460 http://dx.doi.org/10.1186/1756-8722-3-51 |
Ejemplares similares
-
Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GVHD?
por: Gallo, Susanna, et al.
Publicado: (2016) -
Cancers after HLA-matched related Bone Marrow Transplantation for Aplastic Anemia
por: Vo, Phuong, et al.
Publicado: (2021) -
Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia
por: Zhang, Yuanfeng, et al.
Publicado: (2022) -
Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia
por: Liu, Zenghui, et al.
Publicado: (2020) -
Prevalence of somatic mutations in patients with aplastic anemia using peripheral blood cfDNA as compared with BM
por: Albitar, A, et al.
Publicado: (2018)